This value set includes codes based on the following rules:

• Include these codes as defined in http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom

  Code	Display	Definition
  NACHC.B2.DE103	Antinuclear antibodies (ANA)	Hepatitis C Test - Antinuclear antibodies (ANA)
  NACHC.B2.DE104	Hepatitis C antibody	Hepatitis C Test - Hepatitis C antibody
  NACHC.B2.DE105	Hepatitis C antibody; confirmatory test (eg, immunoblot)	Hepatitis C Test - Hepatitis C antibody; confirmatory test (eg, immunoblot)
  NACHC.B2.DE106	Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique	Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique
  NACHC.B2.DE107	Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed	Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed
  NACHC.B2.DE108	Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed	Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed
  NACHC.B2.DE109	Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus	Hepatitis C Test - Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus

• Include these codes as defined in http://www.ama-assn.org/go/cpt

  Code	Display
  1014274	Hepatitis C antibody

• Include these codes as defined in https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets

  Code	Display
  G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)